The Management of Anxiety and Knowledge of Serum CA-125 After an Ovarian Cancer Diagnosis

Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT, USA.
Clinical Journal of Oncology Nursing (Impact Factor: 0.91). 12/2011; 15(6):625-32. DOI: 10.1188/11.CJON.625-632
Source: PubMed


This article describes the relationship among anxiety, distress, and serum CA-125 levels in women with ovarian cancer. Women's anxiety about monitoring their CA-125 levels during chemotherapy also is discussed. Data from a randomized trial including self-reported anxiety and emotional distress of women following surgery after a primary diagnosis of ovarian cancer, their recorded serum CA-125 levels, and knowledge about their CA-125 levels were analyzed. In the sample, 26 of 30 women had serum CA-125 levels above the normal range. At baseline, the sample had an elevated mean anxiety score and an elevated distress score. A moderate association was found between a high serum CA-125 level and a high anxiety score at baseline, but the finding was not statistically significant. A negative nonsignificant relationship was found between a high serum CA-125 level and distress at baseline. The qualitative analysis revealed two themes: anxiety and lack of knowledge of serum CA-125. Oncology nurses and nurse practitioners caring for these women should provide essential information and strategies that can help guide women with ovarian cancer through the journey of their disease.

4 Reads

Similar Publications


4 Reads
Available from